In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: Implications for transplantation

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Watmuff, Bradley ^a   Pouton, Colin W ^a   Haynes, John M ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMINO ACID; CALCIUM ION; CHLORIDE ION; GLUTAMIC ACID; NEUROTOXIN; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; CATECHOLAMINE; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATECHOLAMINE NERVE CELL; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EMBRYO; EMBRYONIC STEM CELL; EXCITOTOXICITY; FLUORESCENCE IMAGING; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; ANIMAL; ANOXIA; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOLOGY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; METHODOLOGY; NERVE CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ANOXIA; CATECHOLAMINES; CELL DIFFERENTIATION; CELL SURVIVAL; DOPAMINERGIC NEURONS; EMBRYONIC STEM CELLS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; NEURONS; STEM CELL TRANSPLANTATION; TYROSINE 3-MONOOXYGENASE;

EID: 84857491742     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031999     Document Type: Article

References (51)

1. Niwa H, (2007) How is pluripotency determined and maintained? Development 134: 635-646.
2. Pouton CW, Haynes JM, (2007) Embryonic stem cells as a source of models for drug discovery. Nat Rev Drug Discov 6: 605-616.
3. Klimanskaya I, Rosenthal N, Lanza R, (2008) Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nature Reviews Drug Discovery 7: 131-142.
4. Han SS, Williams LA, Eggan KC, (2011) Constructing and deconstructing stem cell models of neurological disease. Neuron 70: 626-644.
5. McNeish J, (2004) Embryonic stem cells in drug discovery. Nat Rev Drug Discov 3: 70-80.
6. Morizane A, Li JY, Brundin P, (2008) From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res 331: 323-336.
7. Gaillard A, Jaber M, (2011) Rewiring the brain with cell transplantation in Parkinson's disease. Trends Neurosci.
8. Nishimura F, Yoshikawa M, Kanda S, Nonaka M, Yokota H, et al. (2003) Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells 21: 171-180.
9. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, et al. (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 99: 2344-2349.
10. Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, et al. (2009) Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA Lesioned Rats. Stem Cells Dev.
11. Jonsson ME, Ono Y, Bjorklund A, Thompson LH, (2009) Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis. Exp Neurol 219: 341-354.
12. Hahn M, Timmer M, Nikkhah G, (2009) Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease. J Neurosci Res 87: 2006-2019.
13. Studer L, Tabar V, McKay RD, (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat Neurosci 1: 290-295.
14. Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, et al. (2004) Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22: 1246-1255.
15. Storch A, Lester HA, Boehm BO, Schwarz J, (2003) Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J Chem Neuroanat 26: 133-142.
16. Brundin P, Karlsson J, Emgard M, Schierle GS, Hansson O, et al. (2000) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant 9: 179-195.
17. Liu J, Huang HY, (2007) How to improve the survival of the fetal ventral mesencephalic cell transplanted in Parkinson's disease? Neurosci Bull 23: 377-382.
18. Steiner B, Winter C, Blumensath S, Paul G, Harnack D, et al. (2008) Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument. J Neurosci Methods 169: 128-134.
19. Annett LE, Torres EM, Clarke DJ, Ishida Y, Barker RA, et al. (1997) Survival of nigral grafts within the striatum of marmosets with 6-OHDA lesions depends critically on donor embryo age. Cell Transplant 6: 557-569.
20. Lang RJ, Haynes JM, Kelly J, Johnson J, Greenhalgh J, et al. (2004) Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiation. Eur J Neurosci 20: 3209-3221.
21. Khaira SK, Nefzger CM, Beh SJ, Pouton CW, Haynes JM, (2011) Midbrain and forebrain patterning delivers immunocytochemically and functionally similar populations of neuropeptide Y containing GABAergic neurons. Neurochem Int 59: 413-420.
22. Raye WS, Tochon-Danguy N, Pouton CW, Haynes JM, (2007) Heterogeneous population of dopaminergic neurons derived from mouse embryonic stem cells: preliminary phenotyping based on receptor expression and function. European Journal of Neuroscience 25: 1961-1970.
23. Khaira SK, Pouton CW, Haynes JM, (2009) P2X2, P2X4 and P2Y1 receptors elevate intracellular Ca2+ in mouse embryonic stem cell-derived GABAergic neurons. Br J Pharmacol 158: 1922-1931.
24. Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R, (2007) GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 87: 1215-1284.
25. Pivovarova NB, Andrews SB, (2010) Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J 277: 3622-3636.
26. Preston A, Haynes JM, (2003) alpha(1)-Adrenoceptor effects mediated by protein kinase C alpha in human cultured prostatic stromal cells. Br J Pharmacol 138: 218-224.
27. Grynkiewicz G, Poenie M, Tsien RY, (1985) A NEW GENERATION OF CA-2+ INDICATORS WITH GREATLY IMPROVED FLUORESCENCE PROPERTIES. Journal of Biological Chemistry 260: 3440-3450.
28. Groden DL, Guan Z, Stokes BT, (1991) Determination of Fura-2 dissociation constants following adjustment of the apparent Ca-EGTA association constant for temperature and ionic strength. Cell Calcium 12: 279-287.
29. Inglefield JR, Schwartz-Bloom RD, (1999) Fluorescence imaging of changes in intracellular chloride in living brain slices. Methods 18: 197-203.
30. Krapf R, Berry CA, Verkman AS, (1988) Estimation of Intracellular Chloride Activity in Isolated Perfused Rabbit Proximal Convoluted Tubules Using a Fluorescent Indicator. Biophysical Journal 53: 955-962.
31. Zhao SL, Maxwell S, Jimenez-Beristain A, Vives J, Kuehner E, et al. (2004) Generation of embryonic stem cells and transgenic mice expressing green fluorescence protein in midbrain dopaminergic neurons. European Journal of Neuroscience 19: 1133-1140.
32. di Porzio U, Smith SV, Novotny EA, Morelli F, Barker JL, (1993) Two functionally different glutamate receptors of the kainate subtype in embryonic rat mesencephalic cells. Exp Neurol 120: 202-213.
33. Cordero-Erausquin M, Coull JA, Boudreau D, Rolland M, De Koninck Y, (2005) Differential maturation of GABA action and anion reversal potential in spinal lamina I neurons: impact of chloride extrusion capacity. J Neurosci 25: 9613-9623.
34. Rivera C, Voipio J, Payne JA, Ruusuvuori E, Lahtinen H, et al. (1999) The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397: 251-255.
35. Pignatelli A, Ackman JB, Vigetti D, Beltrami AP, Zucchini S, et al. (2009) A potential reservoir of immature dopaminergic replacement neurons in the adult mammalian olfactory bulb. Pflugers Arch 457: 899-915.
36. Owens DF, Boyce LH, Davis MB, Kriegstein AR, (1996) Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci 16: 6414-6423.
37. Stein V, Hermans-Borgmeyer I, Jentsch TJ, Hubner CA, (2004) Expression of the KCl cotransporter KCC2 parallels neuronal maturation and the emergence of low intracellular chloride. J Comp Neurol 468: 57-64.
38. Khirug S, Huttu K, Ludwig A, Smirnov S, Voipio J, et al. (2005) Distinct properties of functional KCC2 expression in immature mouse hippocampal neurons in culture and in acute slices. European Journal of Neuroscience 21: 899-904.
39. Gruol DL, Netzeband JG, Quina LA, Blakely-Gonzalez PK, (2005) Contribution of L-type channels to Ca2+ regulation of neuronal properties in early developing purkinje neurons. Cerebellum 4: 128-139.
40. He J, Gong H, Luo Q, (2005) BDNF acutely modulates synaptic transmission and calcium signalling in developing cortical neurons. Cell Physiol Biochem 16: 69-76.
41. Dayanithi G, Mechaly I, Viero C, Aptel H, Alphandery S, et al. (2006) Intracellular Ca2+ regulation in rat motoneurons during development. Cell Calcium 39: 237-246.
42. Ibanez-Sandoval O, Carrillo-Reid L, Galarraga E, Tapia D, Mendoza E, et al. (2007) Bursting in substantia nigra pars reticulata neurons in vitro: possible relevance for Parkinson disease. J Neurophysiol 98: 2311-2323.
43. Lobb CJ, Troyer TW, Wilson CJ, Paladini CA, (2011) Disinhibition bursting of dopaminergic neurons. Front Syst Neurosci 5: 25.
44. Cucchiaroni ML, Freestone PS, Berretta N, Viscomi MT, Bisicchia E, et al. (2011) Properties of dopaminergic neurons in organotypic mesencephalic-striatal co-cultures- evidence for a facilitatory effect of dopamine on the glutamatergic input mediated by alpha-1 adrenergic receptors. Eur J Neurosci.
45. Lobb CJ, Wilson CJ, Paladini CA, (2011) High-frequency, short-latency disinhibition bursting of midbrain dopaminergic neurons. J Neurophysiol 105: 2501-2511.
46. Malmersjo S, Liste I, Dyachok O, Tengholm A, Arenas E, et al. (2010) Ca2+ and cAMP signaling in human embryonic stem cell-derived dopamine neurons. Stem Cells Dev 19: 1355-1364.
47. Santhakumar V, Jones RT, Mody I, (2010) Developmental regulation and neuroprotective effects of striatal tonic GABAA currents. Neuroscience 167: 644-655.
48. Goren MZ, Onat F, Ozkara C, Ozyurt E, Eskazan E, et al. (2001) GABA and L-glutamic acid release in en bloc resection slices of human hippocampus: an in vitro microdialysis study. Neurol Sci 22: 297-302.
49. Nunez JL, Alt JJ, McCarthy MM, (2003) A new model for prenatal brain damage. I. GABAA receptor activation induces cell death in developing rat hippocampus. Exp Neurol 181: 258-269.
50. Arundine M, Tymianski M, (2003) Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34: 325-337.
51. Meredith GE, Totterdell S, Beales M, Meshul CK, (2009) Impaired glutamate homeostasis and programmed cell death in a chronic MPTP mouse model of Parkinson's disease. Exp Neurol 219: 334-340.